Elidel and Cordran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elidel (pimecrolimus) and Cordran (flurandrenolide). Common drug interactions include pneumothorax among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Elidel and Cordran. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.

What is Cordran?

Cordran has active ingredients of flurandrenolide. eHealthMe is studying from 342 Cordran users. Check the latest studies of Cordran.



On Jul, 31, 2026

27 people who take Elidel and Cordran together, and have interactions are studied.

Elidel and Cordran drug interactions.

What are the common drug interactions of Elidel and Cordran, by gender? *:

female:

  1. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  2. Dizziness
  3. Ear infection
  4. Hand fracture
  5. Head injury
  6. Night sweats (sweating in night)
  7. Pyelocaliectasis
  8. Reflux laryngitis (voice disorder caused by backflow of stomach fluids to the throat and voice box area)
  9. Rhinitis allergic (inflammation of the nasal airways due to allergy)
  10. Skin lesion

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

What are the common drug interactions of Elidel and Cordran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alopecia (absence of hair from areas of the body)
  2. Hepatomegaly (abnormal enlargement of the liver)
  3. Hodgkin's disease (cancer originating from white blood cells)
  4. Keloid scar (overgrown scars left from skin injuries)
  5. Laryngocele (a congenital anomalous air sac communicating with the cavity of the larynx)
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  7. Asthenia (weakness)
  8. Dizziness
  9. Ear infection
  10. Fatigue (feeling of tiredness)

30-39:

  1. Conjunctivitis (pink eye)
  2. Dry eye (lack of adequate tears)
  3. Ocular rosacea (redness, irritation or burning of the eyes)

40-49:

n/a

50-59:

  1. Thymus disorder (disease of thymus)
  2. Vaginal haemorrhage (vaginal bleeding)
  3. Viral upper respiratory tract infection
  4. Rash
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Alopecia (absence of hair from areas of the body)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Bladder dilatation
  9. Chest discomfort
  10. Depression

60+:

  1. Fatigue (feeling of tiredness)
  2. Abdominal discomfort
  3. Disease progression
  4. Dry eye (lack of adequate tears)
  5. Dry skin
  6. Dry throat
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Eructation (release of gas from the digestive tract)
  10. Erythema (redness of the skin)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 14.81%
  2. Pain: 3 people, 11.11%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.41%
  4. Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.41%
  5. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 7.41%
  6. Itching: 2 people, 7.41%
  7. Haematological Malignancy (cancer that affect blood, bone marrow, and lymph nodes): 2 people, 7.41%
  8. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 7.41%
  9. Cough: 2 people, 7.41%
  10. Constipation: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and Cordran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elidel and Cordran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cordran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elidel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cordran and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus and flurandrenolide (the active ingredients of Elidel and Cordran, respectively), and Elidel and Cordran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: